Log In
person
Innovent Biologics Inc
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (CNY) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (CNY) | Percentage |
| Biopharmaceuticals |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
4.14B | 90.84% |
| Biopharmaceuticals |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.42B | 9.15% |
| Biopharmaceuticals |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
0B | 0.01% |
| keyboard_arrow_down |
Biopharmaceuticals
Biosimilars; sold through distributor
|
4.14B | 90.84% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Biopharmaceuticals
Pharmaceutical Patent Licensing
|
0.42B | 9.15% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Biopharmaceuticals
Contract Research for Drug Manufacturers
|
0B | 0.01% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||